AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Canarypox Virus Vector For IV p53 Vaccine Delivery Safe In Rhesus Macaques.(Brief Article)

Vaccine Weekly

| April 18, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 APR 18 - (NewsRx.com & NewsRx.net) --

by N.R. Saltmarsh, staff medical writer - A potential anti-cancer vaccine has been shown safe at up to 10 times the required dose in rhesus macaques when administered intravenously, and further trials in humans may be warranted, say researchers at Avax Technologies.

About half of cancers overexpress the p53 gene, and development of a vaccine targeting it has been successful in the mouse model, when administered intravenously. Its potential safety in humans has been questioned, however, due to fears of stimulating a damaging autoimmune response.

Brigitte Rosenwirth and colleagues at Avax Technologies, Rensselaer, New York, immunized rhesus macaques with a recombinant canarypox virus, ALVAC, expressing human wild-type p53 (vCP207), which in previous studies had prevented growth of p53-overexpressing tumors in mice.

The researchers gave macaques up to 10 times the proportional dose in humans, with apparently no ill effect ("Safety and immunogenicity of ALVAC wild-type human p53 (VCP207) by the intravenous route in rhesus macaques," Vaccine, 2001;19(13-14):1661-1670).

"Serologic markers ...

Related articles from newspapers, magazines, journals, and more
AVAX Technologies Begins Trading On Nasdaq SmallCap Market
Press release article from: PR Newswire July 9, 1997 700+ words
...Mo., July 9 /PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq: AVXT) announced...securities laws of any such state. AVAX Technologies is a development stage biopharmaceutical...Litigation Reform Act of 1995. Although AVAX Technologies believes that the expectations reflected...
AVAX Technologies Announces 2-For-1 Reverse Stock Split To Meet Nasdaq...
Press release article from: PR Newswire May 7, 1997 700+ words
...Mo., May 7 /PRNewswire/ -- AVAX Technologies, Inc. (OTC: AVAX) announced...shares on a fully diluted basis. AVAX Technologies, Inc. specializes in the development...Litigation Reform Act of 1995. Although AVAX Technologies believes that the expectations reflected...
Progress Review For AVAX Technologies Inc.
Press release article from: M2 Presswire December 11, 2007 700+ words
...streetinvesting.com: Progress Review For AVAX Technologies Inc.(C)1994-2007 M2 COMMUNICATIONS...rate-setting meeting on Tuesday. AVAX Technologies Inc. (OTCBB:AVXT) traded up...various prospective companies therein. AVAX Technologies Inc. was among those that we have...
AVAX Technologies Receives an Additional $3.0 Million (AUD) Investment In...
Press release article from: PR Newswire April 6, 2000 700+ words
...Mo., April 6 /PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq: AVXT) today announced...rights to manufacture and market AVAX Technologies' autologous cancer vaccine (AC...Under the terms of the agreement, AVAX Technologies has been granted an option to purchase...
AVAX Technologies Conditionally Approved For Listing on Nasdaq Small Cap Market
Press release article from: PR Newswire March 26, 1997 700+ words
...Mo., March 26 /PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq: AVAX) announced...time frame specified by the Nasdaq. AVAX Technologies, Inc. specializes in the development...results to differ materially. SOURCE AVAX Technologies, Inc. -0- 03/26/97 /CONTACT...
Progressive Following on AVAX Technologies Inc.
Press release article from: M2 Presswire April 10, 2008 700+ words
...Review: Progressive Following on AVAX Technologies Inc.(C)1994-2008 M2 COMMUNICATIONS...resumed our progressive review of AVAX Technologies Inc. (OTCBB:AVXT) as it traded...various prospective companies therein AVAX Technologies Inc. was among those that we have...
AVAX Technologies to Present at the Acumen Biofin 4th Annual Global Health Care...
Press release article from: Business Wire May 14, 2007 700+ words
PHILADELPHIA -- AVAX Technologies, Inc. (OTCMarket: AVXT...Richard Rainey, President of AVAX Technologies will provide an update on the...after the presentation. About AVAX Technologies, Inc. AVAX Technologies...
AVAX Technologies Receives Final $3.0 Million (AUD) Investment in Australian...
Press release article from: PR Newswire August 23, 2000 700+ words
...Mo., Aug. 23 /PRNewswire/ -- AVAX Technologies, Inc. (Nasdaq: AVXT) today announced...Australia manufactures and markets AVAX Technologies' M-Vax(TM), an autologous...M.D., President and CEO of AVAX Technologies, Inc., stated, "We are very...
For more facts and information, see all results

Source: HighBeam Research, Canarypox Virus Vector For IV p53 Vaccine Delivery Safe In Rhesus...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA